A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Washington has an opportunity to help tens of millions.

Background With declining vectorial transmission, Chagas disease predominantly affects adults nowadays. The efficacy of nifurtimox in the chronic phase in adult patients is poorly known ...

I care deeply because this chronic disease is mine. It lives inside me. It’s radically changed my life and the life of my family. And I don’t want anyone to go through the revolving door of ...

According to the CBL-0201DD Phase 2 ... The pain is chronic (>3 months), symmetrical, often disabling, and resistant to traditional analgesics. The etiology of Dercum's disease remains unknown.

Chagas disease is often referred to as a “silent and silenced disease” since the majority of infected individuals show no symptoms or only extremely mild symptoms. However, if left untreated, the ...

Maggie’s Pearl – a joint venture between the rare disease biotech Perlara, the non-profit organisation Maggie’s Cure, and Mayo Clinic – is sponsoring a Phase III trial of oral epalrestat (NCT04925960) ...

These positive early-stage clinical results provide promising evidence supporting the continued development of XellSmart's XS411 for Parkinson's disease patients. Pioneering Achievements in ...

These positive early-stage clinical results provide promising evidence supporting the continued development of XellSmart's XS411 for Parkinson's disease patients. Pioneering Achievements in ...

(RTTNews) - Atea Pharmaceuticals (AVIR) on Wednesday announced the dosing of the first patient in its C-BEYOND phase 3 trial in ... and ruzasvir for treating chronic hepatitis C virus - HCV ...

It was the last day of his multistate Make American Healthy Again tour, designed to highlight various aspects of Mr. Kennedy’s plan to fight chronic disease ... casino stage, he pointed out ...